Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
S2 Genomics logo — Reimagine your single-cell research with automation.

S2 Genomics

Reimagine your single-cell research with automation.

Founded 2016 United States Livermore, United States 6 employees Acquired Total: $18.20M Biotechnology, Health Care

General Information

Company Name S2 Genomics
Founded Year 2016
Location United States Livermore, United States
Employees 6
Industries Biotechnology, Health Care
Funding Stage Acquired
Business Model B2B, E Commerce
Revenue Model Product Sales, One Time Purchase, Tiered Pricing
Social

BounceWatch is an independent company data service, not affiliated with S2 Genomics. To contact S2 Genomics, visit s2genomics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does S2 Genomics compare?

A PDF of S2 Genomics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting S2 Genomics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About S2 Genomics

S2 Genomics, founded in 2016, is a pioneering company in the fields of Biotechnology and Health Care. With its headquarters in the United States, the company is at the forefront of innovation by providing solutions that automate the conversion of raw tissues into single cells or nuclei, crucial for genomics and cell biology studies.

The company's slogan, "Reimagine your single-cell research with automation," aptly encapsulates its mission to streamline the research process in these scientific fields. By reducing the manual workload, S2 Genomics significantly enhances research efficiency and accuracy.

In a significant milestone, the company secured a $16.00M Series A investment on January 23, 2024. This round was led by prominent investors such as BroadOak Capital Partners, HealthTech Capital, and RCT. This financial backing will likely propel S2 Genomics towards further technological advancements and market penetration, making it an attractive prospect for investors seeking opportunities in the biotechnology sector.

Business keywords: single-cell research, genomics, cell biology, spatial sequencing technology, tissue processing, genomic analyses, startups, innovation

Services & Products

Automated Tissue Dissociation
NIST-traceable Cell Counting
Fluorescence Phenotyping Tools
Precision Instrumentation

Target Customers

Research Institutions Laboratories Biotechnology Companies Medical Research Facilities

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Acquisition Undisclosed 1
Precision Cell Systems
01 Sep 2025
Series A $16.00M 2
BroadOak Capital Partners
BroadOak Capital Partners, Research Corporation Technologies
01 Jan 2024
Convertible Note Undisclosed 1
HealthTech Capital
HealthTech Capital
01 Apr 2022
Debt Financing $2.20M -
01 May 2021
Seed Undisclosed 2
Life Science Angels HealthTech Capital
Life Science Angels, HealthTech Capital
01 Dec 2019
Convertible Note Undisclosed -
01 Aug 2019
Seed Undisclosed 1
Life Science Angels
Life Science Angels
01 Jan 2019

S2 Genomics Alternatives & Competitors

View All Alternatives
S2 Genomics vs
CARTANA
CARTANA United States

Powering researchers’ insights with innovative single cell, spatial biology, & in situ tools. 🧬🔬

IPO
2093 employees
Biotechnology, Health Care
S2 Genomics vs
CS Genetics
CS Genetics United Kingdom

Disruptive platform for single-cell genomics which leverages instrument-free, solution-phase chemica...

24 employees
Biotechnology, Health Care
S2 Genomics vs
Vizgen
Vizgen United States

Confidently take your research to new depths with MERSCOPE Ultra integrating single-cell and spatial...

Series E
153 employees
Biotechnology, Health Care
Also compare with: S2 Genomics vs Mission Bio Mission Bio View all alternatives

FAQ About S2 Genomics

Reimagine your single-cell research with automation.
S2 Genomics was founded in 2016.
S2 Genomics is headquartered in Livermore, United States.
S2 Genomics operates in Biotechnology and Health Care. Its work centres on single-cell research, genomics, cell biology and spatial sequencing technology. Its customers include Research Institutions, Laboratories and Biotechnology Companies.
S2 Genomics has a B2B and E Commerce business model. Its revenue comes from Product Sales, One Time Purchase and Tiered Pricing.
S2 Genomics has approximately 6 employees.
S2 Genomics has completed 7 funding rounds, raising a total of $18.20M. The latest funding stage is Acquired.
S2 Genomics offers: Automated Tissue Dissociation, NIST-traceable Cell Counting, Fluorescence Phenotyping Tools, Precision Instrumentation.
Top alternatives and competitors to S2 Genomics include CARTANA, CS Genetics, Vizgen, Single Cell Discoveries, Mission Bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
S2 Genomics and CARTANA are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for S2 Genomics, https://bouncewatch.com/company/s2-genomics, updated 18 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes